Chemical Component Summary

Name4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)BENZENESULFONAMIDE
Identifiers4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
FormulaC16 H14 N2 O3 S
Molecular Weight314.36
TypeNON-POLYMER
Isomeric SMILESCc1onc(c2ccccc2)c1c3ccc(cc3)[S](N)(=O)=O
InChIInChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)
InChIKeyLNPDTQAFDNKSHK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count36
Chiral Atom Count0
Bond Count38
Aromatic Bond Count19

Drug Info: DrugBank

DrugBank IDDB00580 
NameValdecoxib
Groups
  • approved
  • investigational
  • withdrawn
DescriptionValdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke.
SynonymsValdecoxib
Brand NamesBextra
IndicationFor the treatment of osteoarthritis and dysmenorrhoea
Categories
  • Agents causing hyperkalemia
  • Agents that produce hypertension
  • Amides
  • Analgesics
  • Analgesics, Non-Narcotic
ATC-CodeM01AH03
CAS number181695-72-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...unknowninhibitor
Carbonic anhydrase 2MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS...unknowninhibitor
Carbonic anhydrase 3MAKEWGYASHNGPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVS...unknowninhibitor
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknownsubstrate,inhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682